https://www.genengnews.com/multimedia/webinars/optimizing-personalized-cancer-immunotherapy-manufacturing-using-enzymatic-dna/
0
0
11/16/23 at 8:21pm
Organization
Genetic Engineering & Biotechnology News
Author
Kathy Vuksanaj
In this GEN webinar, our speakers Lisa Caproni, PhD, from Touchlight and Pierre Marschall, PhD, from Odimma Therapeutics will discuss the application of Toughlight’s doggybone DNA (dbDNA™) in the development of a neoantigen for immune oncology.
Create an account
or login to join the discussion